Covered recipient · General Payments record
DAVID GARRISON
General Payments · PY2019–2025
$1,122.32
- Reported across 52 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $408.18 | 19 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $104.47 | 4 |
| Novo Nordisk AS | $83.35 | 4 |
| Amgen Inc. | $62.46 | 3 |
| ABBVIE INC. | $55.20 | 3 |
| Lilly USA, LLC | $38.76 | 2 |
| Abbott Laboratories | $23.95 | 1 |
| Astellas Pharma US Inc | $20.89 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (19)
Sorted by paying entity, then date · as published by CMS
Program year 2025 20192021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.95 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1239967565 | CMS |
| ABBVIE INC. | $20.89 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201905437 | CMS |
| ABBVIE INC. | $19.50 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201905439 | CMS |
| ABBVIE INC. | $14.81 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201905441 | CMS |
| Amgen Inc. | $20.25 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228603660 | CMS |
| Amgen Inc. | $17.30 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228603662 | CMS |
| Amgen Inc. | $24.91 | 09/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228603664 | CMS |
| Astellas Pharma US Inc | $20.89 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238658308 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.60 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1215341454 | CMS |
| AstraZeneca Pharmaceuticals LP | $37.39 | 06/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214793069 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.42 | 09/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214772400 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.06 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1215338122 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.10 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184811765 | CMS |
| Lilly USA, LLC | $19.28 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186592394 | CMS |
| Lilly USA, LLC | $19.48 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186605842 | CMS |
| Novo Nordisk Inc | $21.02 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1192978243 | CMS |
| Novo Nordisk Inc | $20.93 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1192980173 | CMS |
| Novo Nordisk Inc | $20.72 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190288699 | CMS |
| Novo Nordisk Inc | $20.68 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190288107 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.